Form 4 Tracker
Eric Mosbrooker

Chief Commercial Officer · 1 filing · Latest: Feb 27, 2026

Avidity Biosciences, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RNA
ERIC MOSBROOKERSep 3, 2025
Proposed Sale
$47.2319,688$929.9K
RNA
ERIC MOSBROOKERAug 6, 2025
Proposed Sale
$38.26130,807$5.0M